CHRONSEAL

· Kringle Pharma Europe AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHRONSEAL, covering 2010-02-05 to 2010-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers [Phase 1, Phase 2]